Mark Rampy

Chief Business Officer @Sequella, Inc

Rockville, MD, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2016 — Present

Chief Business Officer @Sequella, Inc

View department →

Rockville, MD, US

Sequella is a clinical-stage pharmaceutical company that develops new and better antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company\'s product portfolio addresses devastating global health threats that affect over 3 billion people worldwide.

EDUCATION

N/A

University of Michigan

Ph.D., Pharmacology

N/A

Georgetown University McDonough School of Business

MBA

N/A

Kalamazoo College

Bachelor’s Degree, Chemistry and Economics/Business Administration

SKILLS

Start-UpsBusiness DevelopmentDrug DevelopmentCancerBiopharmaceuticalsCROCommercializationStrategic PlanningManagementClinical TrialsInfectious DiseasesBiotechnologyOncologyDue DiligenceDrug DiscoveryPharmaceutical IndustryFdaStrategyRegulatory AffairsLifesciencesGmpClinical DevelopmentMedical DevicesValidationCross-Functional Team LeadershipBusiness StrategyLife SciencesVaccinesTechnology Transfer

ABOUT MARK RAMPY

Experienced Biopharmaceutical Executive | Entrepreneur | Co-Founder & CEO, Mitomed Inc. | Co-Founder & CBO, Capital Biolabs | CBO Sequella | Business & Corporate Development Consultant | Investor

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.